Welcome to our dedicated page for Dxc Technology SEC filings (Ticker: DXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for DXC Technology Company (NYSE: DXC), a Nevada-incorporated global information technology services provider and enterprise technology and innovation partner. Through these filings, investors and analysts can review how DXC reports on its operations, capital structure, governance, and material events.
DXC’s SEC submissions include Form 8-K current reports describing events such as changes to segment reporting, leadership changes, annual meeting voting results, senior notes offerings, and redemptions of existing debt. For example, DXC has filed 8-Ks detailing the pricing and issuance of 4.250% Senior Notes due 2030 through a wholly owned subsidiary, the planned full redemption and delisting of 1.750% Senior Notes due 2026, and partial redemption of 1.800% Senior Notes due 2026, as well as quarterly earnings releases.
Filings also include Form 25 notifications, such as the removal from listing and/or registration of the 1.750% Notes due 2026 on the New York Stock Exchange. Together with periodic reports like Forms 10-K and 10-Q (when available), these documents outline DXC’s segment structure, risk factors, financing arrangements, and other disclosures relevant to its role in managed infrastructure services, application modernization, insurance services, and industry-specific software solutions.
On Stock Titan, DXC’s SEC filings are updated in near real time from EDGAR and paired with AI-powered summaries to help readers quickly understand the purpose and implications of each document. Long annual reports (Form 10-K) and quarterly reports (Form 10-Q) can be distilled into key themes, while current reports (Form 8-K) are summarized to highlight the nature of each material event. Users can also review filings related to DXC’s debt instruments and other securities, and use the AI explanations to navigate complex indenture terms, covenant descriptions, and capital structure changes more efficiently.
Del Bene Robert F reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology executive vice president and chief financial officer Robert F. Del Bene received an award of 64,604 shares of common stock as part of his regular-cycle FY2024 performance-vesting restricted stock units. The grant was recorded at a price of $0.00 per share as equity compensation rather than an open-market purchase.
The PSUs were earned based on performance metrics measured over a three-year performance period and are scheduled to settle on or around May 23, 2026. Following this award, Del Bene directly holds 397,982 shares of DXC common stock, a figure that includes unvested restricted stock units.
Drumgoole Christopher reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology Co reported that EVP, GIS Christopher Drumgoole received a grant of 85,194 shares of common stock on April 29, 2026, at no purchase price, as part of his equity compensation.
The award consists of regular-cycle FY2024 performance-vesting restricted stock units earned over a three-year performance period and scheduled to settle on or around May 23, 2026. After this grant, Drumgoole directly holds 549,549 shares of DXC common stock, a figure that includes unvested restricted stock units.
DXC Technology Co reported that Chief People Officer Jennifer Ragone received an award of 7,156 shares of common stock as a grant or other acquisition. These shares relate to regular-cycle FY2024 performance-vesting restricted stock units earned over a three-year performance period.
After this award, Ragone beneficially owns 104,216 shares of DXC common stock directly, and this figure includes unvested restricted stock units. The performance stock units are scheduled to settle on or around May 23, 2026, aligning payout with multi-year performance.
Voci Christopher Anthony reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology senior vice president and controller Christopher Anthony Voci reported an award of 15,336 shares of common stock as a grant of performance-vesting restricted stock units. These FY2024 PSUs are earned over a three-year performance period and are scheduled to settle on or around May 23, 2026. After this award, Voci directly holds 98,542 shares of common stock, a figure that the disclosure notes includes unvested restricted stock units. This is a compensation-related equity grant rather than an open-market stock purchase.
August Raymond Alexander reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology executive Raymond Alexander, President of Insurance Software & BPS, reported an equity award of 43,814 shares of Common Stock. The grant consists of FY2024 performance-vesting restricted stock units (PSUs) earned over a three-year performance period and scheduled to settle on or around May 23, 2026. There was no purchase price, reflecting compensation rather than an open-market buy. After this award, Alexander directly holds 371,946 shares of Common Stock, which the disclosure notes includes unvested restricted stock units.
American Century entities reported beneficial ownership stakes in DXC Technology Company Common Stock. The filing lists holdings as of 03/31/2026, showing American Century ETF Trust with 8,706,339 shares (5.1%) and American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research each with 9,074,619 shares (5.4%). The schedule identifies voting and dispositive power as sole for those holdings and states the filings were signed on 05/01/2026.
Vanguard Capital Management reported beneficial ownership of 8,883,306 shares of DXC Technology Co. The filing shows this equals 5.23% of the class and that Vanguard has sole dispositive power over 8,883,306 shares and sole voting power over 1,296,265 shares.
The filing is a Schedule 13G for Common Stock (CUSIP 23355L106) dated 03/31/2026 and signed on 04/29/2026. The report states holdings include shares held for Vanguard funds and managed accounts under Vanguard Capital Management and affiliated business divisions.
DXC Technology Co reported that Vanguard Portfolio Management beneficially owns 13,143,240 shares of common stock, representing 7.74% of the class. The filing shows sole dispositive power over 13,143,240 shares and sole voting power for 247,989 shares, per the Schedule 13G disclosure.
DXC Technology Co Schedule 13G: Glenview Capital Management and Larry Robbins report beneficial ownership of 8,895,875 shares of Common Stock, representing approximately 5.2% of the outstanding shares. Shares outstanding were 169,759,963 as of January 20, 2026.
The filing states the reported stake consists of 3,753,999 shares held for Glenview Capital Master Fund and 5,141,876 shares held for Glenview Offshore Opportunity Master Fund, with shared voting and dispositive power over the full amount.
DXC Technology Co received an amended Schedule 13G filing showing that The Vanguard Group reports zero shares beneficially owned of DXC Common Stock following an internal realignment effective January 12, 2026. The filing states Vanguard disaggregated certain subsidiaries and business divisions to report separately in reliance on SEC Release No. 34-39538.
The amendment is signed by Vanguard's Head of Global Fund Administration and records 0 shares (0%) beneficially owned as of the filing.